Valentino Cattori

Title: Valentino Cattori: Innovator in Pharmaceutical Compounds

Introduction

Valentino Cattori, an accomplished inventor located in Wadenswil, Switzerland, has made significant contributions to the field of pharmaceutical science. With a total of three patents to his name, Cattori is renowned for his innovative work on oxopiperazine derivatives.

Latest Patents

Cattori's latest patents focus on novel compounds of formula (I) and formula (Ia), which include pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers. These compounds, along with their pharmaceutical compositions, are designed for both preventive and therapeutic use in human and veterinary medicine. His contributions in this domain emphasize the importance of innovation in developing new medical treatments.

Career Highlights

Currently, Valentino Cattori is associated with Inthera Bioscience AG, a company that is recognized for its cutting-edge research and developments in the biopharmaceutical sector. His work within this institution showcases his commitment to advancing medical science through innovative solutions.

Collaborations

Throughout his career, Cattori has collaborated with notable colleagues such as Marc A Labelle and Ulrich Kessler. These partnerships have enriched his research endeavors and have facilitated the advancement of his patented compounds, allowing for shared knowledge and expertise in the development of novel therapeutics.

Conclusion

Valentino Cattori exemplifies the spirit of innovation necessary for progress in the medicinal field. With his multiple patents and collaborative efforts, he continues to play a crucial role in the creation of impactful pharmaceutical compounds that serve both human and veterinary needs.